RFC
LXRX icon

Russell Frank Company’s Lexicon Pharmaceuticals LXRX Stock Holding History

Russell Frank Company’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.94M Buy
162,369
+135,759
+510% +$1.42M ﹤0.01% 1866
2015
Q4 		$356K Sell
26,610
-829
-3% -$10.2K ﹤0.01% 2568
2015
Q3 		$295K Sell
27,439
-31,066
-53% -$339K ﹤0.01% 2633
2015
Q2 		$471K Buy
+58,505
New +$430K ﹤0.01% 2596
2015
Q1 		– Sell
-8,043
Closed -$49K – 3006
2014
Q4 		$49K Buy
+8,043
New +$64.8K ﹤0.01% 2802
2013
Q4 		– Sell
-2,368
Closed -$39K – 2933
2013
Q3 		$39K Buy
2,368
+623
+36% +$10.4K ﹤0.01% 3154
2013
Q2 		$26K Buy
+1,745
New +$26.5K ﹤0.01% 2969

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return